ArticleSince its inception in 2018, Redcliffe Labs has endeavoured to be a disrupter in India’s lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete ‘Glucose to Genetics’ approach.
Redcliffe Labs founder discusses new era of diagnostics in India
Dapatkan kabar dan info terbaru dari LabInsights
Lainnya dalam topik yang sama
Dapatkan kabar dan info terbaru dari LabInsights
Bacaan Berikutnya
- Healthcare Transformation, Management, Operations, Population Health Management
- Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
- Clinician Engagement, Coagulation, Disease Area, Management
